Form 4 Tracker
HALOZYME THERAPEUTICS, INC.
HALO

42 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 8, 2026Oct 8 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$109.40$2.2M767,780(D)

View →

Oct 7, 2026Oct 8 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$111.55$2.2M767,780(D)

View →

Oct 6, 2026Oct 8 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$109.58$2.2M767,780(D)

View →

Oct 1, 2026Oct 2 8:38 PMMatthew L. PosardDirector
Sale
5,230$108.54$567.7K53,609(D)

View →

Sep 16, 2026Sep 17 9:19 PMMatthew L. PosardDirector
Sale
18,996$107.74$2.0M58,839(D)

View →

Sep 16, 2026Sep 16 8:41 PMMATTHEW POSARD
Proposed Sale
34,226$106.25$3.6M—

View →

Sep 11, 2026Sep 12 12:35 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$107.24$2.1M767,780(D)

View →

Sep 10, 2026Sep 12 12:35 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$107.17$2.1M767,780(D)

View →

Sep 9, 2026Sep 12 12:35 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$107.43$2.1M767,780(D)

View →

Aug 19, 2026Aug 20 12:01 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$107.00$2.1M767,780(D)

View →

Aug 18, 2026Aug 20 12:01 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$104.18$2.1M767,780(D)

View →

Aug 17, 2026Aug 20 12:01 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$102.60$2.1M767,780(D)

View →

Aug 17, 2026Aug 17 9:16 PMHelen Torley
Proposed Sale
240,000$98.66$23.7M—

View →

Aug 11, 2026Aug 11 9:57 PMCORTNEY A CAUDILL
Proposed Sale
41,702$103.17$4.3M—

View →

Aug 10, 2026Aug 11 9:43 PMBernadette ConnaughtonDirector
Sale
1,626$102.80$167.2K40,418(D)

View →

Aug 10, 2026Aug 10 8:34 PMBERNADETTE CONNAUGHTON
Proposed Sale
1,626$103.12$167.7K—

View →

Jul 8, 2026Jul 9 9:19 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
1,923$79.77$153.4K767,780(D)

View →

Jul 1, 2026Jul 2 8:42 PMBernadette ConnaughtonDirector
Sale
1,625$76.71$124.7K42,044(D)

View →

Jun 29, 2026Jun 30 9:25 PMMahesh KrishnanDirector
Sale
7,304$75.00$547.8K14,462(D)

View →

Jun 29, 2026Jun 29 8:41 PMMAHESH KRISHNAN
Proposed Sale
7,304$74.96$547.5K—

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 20, 2026Feb 24 11:16 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
6,688$0.0036,357(D)

View →

Feb 20, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
22,436$0.0044,872(D)

View →

Feb 20, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
16,757$0.0050,270(D)

View →

Feb 16, 2026Feb 17 11:53 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
16,812$0.000(D)

View →

Feb 16, 2026Feb 17 11:52 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
23,773$0.000(D)

View →

Feb 16, 2026Feb 17 11:51 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
89,055$0.000(D)

View →

Feb 9, 2026Feb 12 2:21 AMCortney CaudillSVP, CHIEF OPERATING OFFICER
Grant/Award
44,248$80.4814,751(D)

View →

Feb 9, 2026Feb 12 2:20 AMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Grant/Award
78,087$80.4829,502(D)

View →

Feb 9, 2026Feb 12 2:20 AMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Grant/Award
42,117$0.0029,502(D)

View →

Feb 9, 2026Feb 12 1:56 AMHelen TorleyDirector, PRESIDENT AND CEO
Grant/Award
241,366$80.4892,714(D)

View →

Feb 5, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07201,923(D)

View →

Feb 4, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07211,923(D)

View →

Feb 3, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07231,923(D)

View →

← Previous

Page 3 of 3